Open AccessFollow-up and prognosis of HCM
Author(s) -
Fernándo Domínguez,
Jorge Sanz Sánchez,
Pablo GarcíaPavía,
Esther Zorio
Publication year - 2018
Publication title -
global cardiology science and practice
Language(s) - English
Resource type - Journals
ISSN - 2305-7823
DOI - 10.21542/gcsp.2018.33
Subject(s) - hypertrophic cardiomyopathy , medicine , ventricular outflow tract obstruction , cardiology , sudden cardiac death , sudden death , cardiomyopathy , heart failure
[first paragraph of article] The frequency of follow-up visits in hypertrophic cardiomyopathy (HCM) patients is mainly determined by their symptoms, age and severity of disease. Clinical visits should focus on sudden cardiac death (SCD) and embolic risk-assessment, changes in symptoms, cardiac rhythm, left ventricular outflow tract obstruction (LVOTO) and left ventricular (LV) systolic function.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom